ÌÇÐÄvlog

[Skip to Navigation]
Sign In
Teachable Moment
Less Is More
October 26, 2020

Implantable Cardioverter Defibrillator Management at the End of Life: A Teachable Moment

Author Affiliations
  • 1Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas
JAMA Intern Med. 2020;180(12):1691-1692. doi:10.1001/jamainternmed.2020.5041

An 87-year-old man with nonischemic cardiomyopathy, an implantable cardioverter defibrillator (ICD), and stage IV renal cell carcinoma presented to the emergency department with fever. On arrival, his temperature was 103 °F, his heart rate 120 beats per minute, and his blood pressure 80/56 mm Hg. His laboratory results were notable for a white blood cell count of 16 000/μL (to convert to ×109/L, multiply by 0.001) and urinalysis showing leukocyte esterase, nitrites, and bacteria. His condition initially improved with volume resuscitation and treatment with ceftriaxone and was admitted with sepsis presumed secondary to a urinary source. On admission, the patient reported that he had previously signed an out-of-hospital do-not-resuscitate (DNR) order and that he wanted to continue his DNR status while hospitalized.

Add or change institution
1 Comment for this article
EXPAND ALL
Timeliness of Article
Archer Macy, BS, MS, MA | Patient & Family Member
It is interesting to see this article at this time. My father had an AICD and was dying in 1996 from cancer. He was at home, being cared for by my brother who was a RN. It took my brother an unholy effort to get someone to bring him a magnet and show him how to to deactivate the AICD. As our father was passing, my brother was able to deactivate the AICD, so he didn't have to go through the experience cited in this article.

I hope this awareness gets out into the whole community
quickly to prevent further occurrences of this terrible but preventable circumstance.
CONFLICT OF INTEREST: None Reported
READ MORE
×